Shares of Avantor, Inc. (NYSE:AVTR – Get Free Report) have earned an average rating of “Moderate Buy” from the thirteen ratings firms that are presently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $27.69.
AVTR has been the topic of a number of recent research reports. Wells Fargo & Company dropped their target price on Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. Royal Bank of Canada reissued an “outperform” rating and issued a $34.00 price objective on shares of Avantor in a research note on Thursday, September 26th. UBS Group reduced their target price on shares of Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a research note on Tuesday, October 8th. Barclays dropped their price target on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research note on Friday, October 25th. Finally, Robert W. Baird reduced their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research report on Monday, October 28th.
View Our Latest Stock Report on AVTR
Hedge Funds Weigh In On Avantor
Avantor Stock Down 0.0 %
AVTR opened at $21.07 on Thursday. Avantor has a 52 week low of $19.59 and a 52 week high of $28.00. The business has a 50 day moving average price of $21.63 and a two-hundred day moving average price of $23.34. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84. The company has a market cap of $14.34 billion, a PE ratio of 45.80, a P/E/G ratio of 2.75 and a beta of 1.29.
About Avantor
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Featured Stories
- Five stocks we like better than Avantor
- What is the Australian Securities Exchange (ASX)
- Work and Play: Investing in the Rise of Bleisure Travel
- About the Markup Calculator
- Top Dividend Stocks to Buy Now as Bond Yields Could Lower
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- SAP: AI Tailwinds Accelerating Enterprise Cloud Business
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.